Concepedia

Publication | Open Access

Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis

DOIFull Paper Access

89

Citations

21

References

2019

Year

Kelvin Chan, Helen Guo, Sierra Cheng, Jaclyn Beca, Ruby Redmond‐Misner, Wanrudee Isaranuwatchai, Lucy Qiao, Craig C. Earle, Scott R. Berry, James Biagi,
Cancer Medicine

Abstract

In the real world, FFX had longer OS, less frequent all-cause EDV and all-cause hospitalization, but more febrile neutropenia-related hospitalization compared to GnP.

References

YearCitations

Page 1